Fig. 4From: Effects of the Toll-like receptor 7 (TLR7) agonist, AZD8848, on allergen-induced responses in patients with mild asthma: a double-blind, randomised, parallel-group studyPercentage changes in FEV1 at a) baseline, b) 1 week and c) 4 weeks after end of treatmentBack to article page